It is well-accepted that either ACE inhibitors or AT1 blockers are the gold standard drugs in order to manage hypertension, due their survival benefits provided on patients with heart failure, high cardiac risk profile and also proteiunuric chronic kidney disease [66]. This evidence concerns the gene AGTR1 and Hypertension.